2022
DOI: 10.1186/s12874-022-01514-y
|View full text |Cite
|
Sign up to set email alerts
|

Study retention and attrition in a longitudinal cohort study including patient-reported outcomes, fieldwork and biobank samples: results of the Netherlands quality of life and Biomedical cohort study (NET-QUBIC) among 739 head and neck cancer patients and 262 informal caregivers

Abstract: Background Longitudinal observational cohort studies in cancer patients are important to move research and clinical practice forward. Continued study participation (study retention) is of importance to maintain the statistical power of research and facilitate representativeness of study findings. This study aimed to investigate study retention and attrition (drop-out) and its associated sociodemographic and clinical factors among head and neck cancer (HNC) patients and informal caregivers inclu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 22 publications
0
19
0
Order By: Relevance
“…Data were used of 739 patients with HNC participating in the prospective NETherlands Quality of Life and Biomedical Cohort study in HNC cancer (NET-QUBIC), of which details were published previously [32,33]. Recruitment took place in 7 HNC centers throughout the Netherlands between 2014 and 2018.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Data were used of 739 patients with HNC participating in the prospective NETherlands Quality of Life and Biomedical Cohort study in HNC cancer (NET-QUBIC), of which details were published previously [32,33]. Recruitment took place in 7 HNC centers throughout the Netherlands between 2014 and 2018.…”
Section: Methodsmentioning
confidence: 99%
“…All patients signed written informed consent before participation. The study protocol of this prospective observational cohort study was approved by the Medical Ethics Committee of the VUmc (NL45051.029.13) and all local participating centers [32,33]. In the present study, patients were included when they had completed the SWAL-QOL questionnaire at any given time point.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Reasons for drop-out are shown in Figure 1. More detailed information on the study flow is provided in a previous published study [30].…”
Section: Study Populationmentioning
confidence: 99%
“…51 Another proposed solution to loss-to-follow-up is to oversample specific subgroups such as those with higher comorbidity or higher risk of mortality. 50 Third, most of the studies we reviewed were relatively small, ranging from 10 to 217 (median 52) participants. This is of particular importance due to the heterogeneity of HNC survivors that receive a range of treatments with physical, psychological, socioeconomic, and other late effects that differ substantially based on patient-factors, cancer-extent and treatments.…”
Section: Discussionmentioning
confidence: 99%